Confirmation of the safety and efficacy of long-term use of CBD food products

Medical staff and patients with complex chronic diseases who receive hemp plant -rich foods cannabidiol used orally for more than 24 consecutive months confirm the safety of their use. It is a fact that the regular use of oral CBD food products improves the condition of patients suffering from various types of pain, the quality of sleep, as well as their overall health.

According to data published in the journal PLOS One , patients who were allowed to consume oral cannabidiol -rich plant-based cannabidiol foods saw a steady improvement in their health status.

cannabidiol -rich hemp foods in a group of nearly 4,000 Australian patients who were prescribed their use. Participants did not use cannabis before they were included in the study. All participants in the study consumed CBD food orally for two years.

According to the authors of the study, “This is the largest and longest-running real-life analysis of the efficacy and safety of GMPs [good manufacturing practices] like oral use of the therapeutic properties of cannabis in a group registry with continuous use. 3961 heterogeneous cannabis-naive patients with a wide range of ages, clinical and complex conditions who were prescribed oral hemp foods rich in natural cannabidiol demonstrated rapid and significant improvement across all study patients and confirmed clinical outcomes. … Hemp foods rich in natural Cannabidiol used orally is well tolerated. The safety of their use is especially important compared to the insecurity and tolerability of traditionally prescribed long-acting opioids .”

The study team concluded that “This large Australian cohort registry of previously cannabis-naive patients with complex chronic conditions receiving cannabis-rich cannabidiol -rich foods orally for more than 24 consecutive months confirms the safety of their use. It is a fact that the regular use of oral CBD food products improves the condition of patients suffering from various types of pain, the quality of sleep, as well as their overall health.

Commentary of the specialists of the Association “Ukrainian Industrial Hemp”

In connection with the published information of our Australian colleagues, I would like to draw attention to one loud-speaking fact, which we constantly focus on. In Germany, where CBD pharmacological preparations are provided to patients within the framework of state insurance programs (i.e. free of charge), refusal of them reaches about 40% due to negative side effects from the use of CBD drugs that are greater than the therapeutic effect achieved through their regular use. use.

< Previous article   C next article >